23
Pharmacokinetics and Pharmacodynamics: Rational dosing and time course Lecture 2

Lecture 2. Clearance Ability to eliminate the drug Volume of distribution (Vd) The measure of the apparent space in the body available to contain

Embed Size (px)

Citation preview

Pharmacokinetics and Pharmacodynamics: Rational dosing and time course

Pharmacokinetics and Pharmacodynamics: Rational dosing and time courseLecture 2Pharmacokinetic factors affecting dosingClearanceAbility to eliminate the drugVolume of distribution (Vd)The measure of the apparent space in the body available to contain the drugRelates the amount of drug in the body to the concentration of the drug in blood or plasmaIt is the volume apparently necessary to contain the amount of drug homogeneously at the concentration found in the blood or plasma or waterHigh Vd = higher concentration in extravascular tissue than in blood not homogeneously distributed.Pharmacokinetic factors affecting dosingClearanceAdditive character of clearanceElimination may occur in the kidneys, liver, lungs, etc.Major sites are kidneys and liverFirst order eliminationRate of drug elimination is directly proportional to concentrationRate of elimination may be saturable, if drug is given high enough (Vmax = maximum elimination capacity)Zero order eliminationRate of drug elimination is constant or independent of concentrationPharmacokinetic factors affecting dosingClearanceZero order elimination will follow first order elimination at low concentrations3 common drugs that follow zero order eliminationEthanolPhenytoinAspirinPharmacokinetic factors affecting dosingClearance and half lifeHalf-life (t) = the time required to change the amount of drug in the body by one half during elimination (or during constant infusion)Indicates the time required to attain 50% of steady state or to decay 50% from steady state conditionsSteady state = maximum drug level where there is an equilibrium between administration and eliminationWill be achieved after 4 half lives have elapsedUseful in determining drug dosage regimensDrug infusion at constant rate

4 half lives is need to to achieve steady state6Pharmacokinetic factors affecting dosingClearance and half lifeDrug accumulation = if dosing interval is shorter than four half livesPharmacokinetic factors affecting dosingBioavailabilityThe fraction of unchanged drug reaching the systemic circulation, following administration by any routeAfter administration, drugs need to be absorbed and pass through several compartments (depending on the route of administration)Absorption (ex. intestines, blood, body compartments, etc)Elimination (orally administered drugs will pass thru the liver first)Pharmacokinetic factors affecting dosingBioavailabilityExtent of absorptionDepends on drug characteristics (lipophylic, hydrophilic, pH, etc)If too hydrophilic = difficult time to pass thru the cell membraneIf too lipophilic = difficult to enter the blood plasmaSome drugs are actively pumped back into the gut lumen (ex. P-glycoprotein transporter)Drinking grapefruit juice will inhibit the P-glycoprotein transporter, thus increasing drug absorptionPharmacokinetic factors affecting dosingBioavailabilityExtent of absorptionAbsorption rate also follows zero-order and first-order absorptionZero order: rate of absorption is independent of drug concentrationFirst order: rate of absorption is proportional to drug concentration in the gut (which is saturable)RouteBioavailability (%)CharacteristicsIV100 (by definition)Most rapid onsetIM75-100Large volumes often feasible; may be painfulSC75-100Smaller volumes than IM; may be painfulOral5 to